Blennow K - Search Results

1

The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease.

Wang YT, Ashton NJ, Servaes S, Nilsson J, Woo MS, Pascoal TA, Tissot C, Rahmouni N, Therriault J, Lussier F, Chamoun M, Gauthier S, Brinkmalm A, Zetterberg H, Blennow K, Rosa-Neto P, Benedet AL. Wang YT, et al. Among authors: blennow k. Transl Neurodegener. 2024 May 28;13(1):27. doi: 10.1186/s40035-024-00420-1. Transl Neurodegener. 2024. PMID: 38802928 Free PMC article. No abstract available.

2

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

3

The neurochemistry of Alzheimer's disease.

Blennow K, Cowburn RF. Blennow K, et al. Acta Neurol Scand Suppl. 1996;168:77-86. doi: 10.1111/j.1600-0404.1996.tb00378.x. Acta Neurol Scand Suppl. 1996. PMID: 8997425 Review.

4

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R. Nilsson CL, et al. Among authors: blennow k. Peptides. 2001 Dec;22(12):2105-12. doi: 10.1016/s0196-9781(01)00571-x. Peptides. 2001. PMID: 11786197

5

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Blennow K, Vanmechelen E, Hampel H. Blennow K, et al. Mol Neurobiol. 2001 Aug-Dec;24(1-3):87-97. doi: 10.1385/MN:24:1-3:087. Mol Neurobiol. 2001. PMID: 11831556 Review.

6

No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease.

Zetterberg H, Coppola A, D'Angelo A, Palmér M, Rymo L, Blennow K. Zetterberg H, et al. Among authors: blennow k. Thromb Res. 2002 Nov 1;108(2-3):127-31. doi: 10.1016/s0049-3848(03)00004-5. Thromb Res. 2002. PMID: 12590948 No abstract available.

7

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia.

Johansson A, Hampel H, Faltraco F, Buerger K, Minthon L, Bogdanovic N, Sjögren M, Zetterberg H, Forsell L, Lilius L, Wahlund LO, Rymo L, Prince JA, Blennow K. Johansson A, et al. Among authors: blennow k. Neurosci Lett. 2003 Apr 3;340(1):69-73. doi: 10.1016/s0304-3940(03)00051-x. Neurosci Lett. 2003. PMID: 12648761

8

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren M, Andreasen N, Blennow K. Sjögren M, et al. Among authors: blennow k. Clin Chim Acta. 2003 Jun;332(1-2):1-10. doi: 10.1016/s0009-8981(03)00121-9. Clin Chim Acta. 2003. PMID: 12763273 Review.

9

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease.

Zetterberg H, Nexö E, Regland B, Minthon L, Boson R, Palmér M, Rymo L, Blennow K. Zetterberg H, et al. Among authors: blennow k. Clin Chem. 2003 Jul;49(7):1195-8. doi: 10.1373/49.7.1195. Clin Chem. 2003. PMID: 12816923 No abstract available.

10

Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion.

Zetterberg H, Zafiropoulos A, Spandidos DA, Rymo L, Blennow K. Zetterberg H, et al. Among authors: blennow k. Hum Reprod. 2003 Sep;18(9):1948-50. doi: 10.1093/humrep/deg375. Hum Reprod. 2003. PMID: 12923155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,206 results

Search Page

Filters